Atezolizumab has good showing as first-line therapy in urothelial cancerJune 13, 2016Genitourinary Cancer
MyPathway: Targeted therapies show promise in nonindicated tumorsJune 8, 2016GastroenterologyLung CancerBreast CancerGenitourinary CancerHead & Neck/Thyroid CancersMelanomaRare Diseases
VIDEO: Immune checkpoint inhibitor is efficacious as first-line therapy for advanced bladder cancerJune 6, 2016Genitourinary Cancer
FDA approves lenvatinib for advanced renal cell carcinomaMay 16, 2016Genitourinary CancerRenal Cell Carcinoma
NCI: Use of dug wells in New England linked with risk of bladder cancerMay 6, 2016Genitourinary Cancer
Feds advance cancer moonshot with expert panel, outline of goalsApril 5, 2016Breast CancerGenitourinary CancerGynecologic CancerLung CancerRare DiseasesSarcoma & GIST
PSA screens could be cost effective if low-risk cases went untreatedApril 4, 2016Genitourinary Cancer
